Deutsch
A A A
Bereichsnavigation

Previous
RHÖN-KLINIKUM AG | 04/25/2013

Accounts press conference in Frankfurt am Main on 25 April 2013

Annual results 2012

  • Renewed increase in patients treated of 12.2 % is evidence of confidence in the quality of care and medical capability
  • 9.0 % revenue growth in a challenging regulatory environment
  • Growth driven by the integration of the HSK in Wiesbaden
  • 42.9 % decline in earnings, mainly due to setbacks in the UKGM restructuring and other non-recurring charges

Results of Q1 2013

  • Increase of 60,781 or 10.0 % in number of patients to a total of 670,677 cases underlines a good start to the new financial year
  • Revenue grows by 10.2 % to €752.2 million
  • Consolidated net profit decreases by €9.8 million or 28.7 % to €24.3 million
  • EBIT falls by €8.6 million or 17.7 % to €39.9 million
  • EBITDA shrinks by €6.9 million or 8.4 % to €74.9 million

In 2012, nearly 2.6 million patients were treated in the Group’s hospitals. In the same period, revenue rose to €2.86 billion. Due to setbacks in the restructuring of the University Hospital Gießen and Marburg (UKGM), non-recurring charges connected to the Fresenius takeover bid, increased regulatory pressure and a negative contribution from Dr. Horst Schmidt Kliniken Wiesbaden (HSK), which was consolidated for the first time in 2012, consolidated net profit fell 42.9 % to €92.0 million. EBITDA, adjusted for the effect of the Siemens compensation payment with regard to “PTZ Marburg” in the 2011 financial year, declined by 13.7 % to €291.5 million year-on-year, and EBIT fell 29.5 % to €150.3 million.

“Despite the eventful and difficult 2012 financial year, RHÖN-KLINIKUM AG’s revenue and patient numbers are rising steadily. The continuing attractiveness of our services is clearly strengthened by this show of confidence. Nonetheless, the cost situation overall is unsatisfactory,” said Dr Martin Siebert, Chairman of the Board of Management at RHÖN-KLINIKUM AG.

At this year’s Annual General Meeting on 12 June 2013, the Board of Management and Supervisory Board will propose a dividend distribution of €0.25 (previous year: €0.45) per share entitled to dividend (DE 0007042301; 138,232,000 shares).

Jobs 2012

As of 31 December 2012, RHÖN-KLINIKUM AG employed 43,059 people in ten German states. That is once again more than the year before. In many regions, the hospitals of the RHÖN-KLINIKUM Group are among the largest employers.

Results of Q1 2013

670,677 patients were treated in the first three months of the current financial year (+10.0 %). Revenue grew to €752.2 million (+10.2 %). 
Consolidated net profit fell by 28.7 % to €24.3 million. EBITDA decreased to €74.9 million (-8.4 %). EBIT declined to €39.9 million and is thus 17.7 % lower than in the previous year.

Outlook for 2013

The company has confirmed its forecast for 2013 as a whole. In 2013, RHÖN-KLINIKUM AG expects revenue of €3.03 billion, plus or minus 2.5 %. This revenue target is accompanied by an EBITDA forecast of €325 million and a consolidated net profit forecast of €110 million, each with a fluctuation range of +/- 5 %.

“We are confident that the structural, procedural and staffing measures of recent months have laid the first important foundations for making the company more competitive, so that RHÖN-KLINIKUM AG can return to where we believe it belongs: at the very top of the market. The institutional basis for this will be provided by a systematic Group-wide optimisation programme, currently being launched, which relates to our traditional strengths and also enriches our tried-and-tested business model with fresh stimulus,” said Dr Martin Siebert, Chairman of the Board of Management at RHÖN-KLINIKUM AG.

“The goal is clear: step by step, we want to rebuild the company as an integrated health group, in which knowledge, skills, technologies and processes are first and foremost systematically shared and closely interlinked to a much greater degree than before. In the future, a strengthened University Hospital Gießen and Marburg will play a more important role as a ‘medical technology hub’ for all Group hospitals,” the Board of Management Chairman said.

Wiesbaden’s Dr. Horst Schmidt Kliniken (HSK) is being integrated into the company ‘energetically’: “We are on budget and expect to achieve the first positive monthly results in the third quarter of this year. Achieving our profitability targets is therefore not an end in itself, but rather the necessary financial requirement not only to uphold our long-held credo of affordable top-quality medical care for everyone, but also to improve on it,” said Siebert.